3//SEC Filing
OREXIGEN THERAPEUTICS INC 3
Accession 0001178913-10-002128
CIK 0001278906other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 9:18 AM ET
Size
19.4 KB
Accession
0001178913-10-002128
Insider Transaction Report
Form 3
SENATOR RON
Other
Holdings
- 591,877(indirect: Sphera Global Healthcare Management L.P.)
Common Stock
BREEN DORON
Other
Holdings
- 591,877(indirect: Sphera Global Healthcare Management L.P.)
Common Stock
Holdings
- 591,877(indirect: Sphera Global Healthcare Management L.P.)
Common Stock
MOR ISRAEL
Other
Holdings
- 591,877(indirect: Sphera Global Healthcare Management L.P.)
Common Stock
Footnotes (3)
- [F1]These securities are beneficially owned by Sphera Global Healthcare Fund, which invests substantially all of its assets in Sphera Global Healthcare Master Fund. Sphera Global Healthcare Fund and Sphera Global Healthcare Master Fund have delegated all investment decision-making to Sphera Global Healthcare Management L.P. (the "Management Company"). The Management Company is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd. (the "General Partner"), the shares of which are owned 50% by M. Arkin (1999) Ltd. (the "1999 Company") and 50% by Sphera Funds Management Ltd. ("SFML").
- [F2]The 1999 Company, wholly-owned by Moshe Arkin, and SFML are each entitled to appoint two members to the board of directors of the General Partner (the "Board of Directors") and two members to the investment committee of the Management Company (the "Investment Committee"). No decision can be made by either the Board of Directors or the Investment Committee without the consent of both Mr. Arkin's designees and the designees of SFML (Sphera Global Healthcare Fund, Sphera Global Healthcare Master Fund, the Management Company, and the General Partner are referred to collectively in this Form 3 as "Healthcare Fund Entities"). In addition, 62.09% of the shares of SFML are owned by companies controlled or wholly-owned by the three founders of SFML, Israel Mor, Doron Breen, and Ron Senator, each of whom currently serves as a director of SFML.
- [F3]The filing of this Form 3 shall not be construed as an admission that SFML, Mr. Breen, Mr. Mor, or Mr. Senator is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the shares of Common Stock of the Company owned by the Healthcare Fund Entities. Pursuant to Rule 16a-1, SFML, Mr. Breen, Mr. Mor, and Mr. Senator disclaims beneficial ownership of the shares of the Company reported herein that are beneficially owned by the Healthcare Fund Entities, except to the extent of their pecuniary interest therein.
Issuer
OREXIGEN THERAPEUTICS INC
CIK 0001278906
Entity typeother
Related Parties
1- filerCIK 0001278906
Filing Metadata
- Form type
- 3
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 9:18 AM ET
- Size
- 19.4 KB